'Preimplantation Genetic Diagnosis 2018: Current Practice and Beyond', 9-10 November 2018
Page URL: https://www.bionews.org.uk/page_96108

The fertility sector has a problem when it comes to IVF add-ons

24 July 2017
By BioNews
Appeared in BioNews 910

This is the fourth in a series of videos filmed at the Progress Educational Trust (PET)'s recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'. (If you cannot see the video below, click here to view it.)

The video features Dr Raj Mathur, Consultant Gynaecologist and Lead for Reproductive Medicine at St Mary's Hospital in Manchester, who addresses controversies surrounding IVF 'add-ons' and argues that the fertility sector has a problem.

The video was produced by Annabel Slater, Genetics Editor at PET and BioNews.

SOURCES & REFERENCES
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
3 July 2017 - by BioNews 
The third in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...
26 June 2017 - by BioNews 
The second in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...
19 June 2017 - by BioNews 
The first in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...
8 May 2017 - by Shaoni Bhattacharya 
The UK's fertility regulator, the HFEA, says it will be investigating a series of allegations concerning the fertility industry made by the Daily Mail newspaper last week...
3 April 2017 - by Antony Blackburn-Starza 
The controversial issue of IVF 'add-ons' – techniques and treatments offered to fertility patients on top of standard IVF – has been the subject of intense debate and media attention since last November's BBC Panorama's documentary, which claimed that many techniques advertised on fertility clinics websites were not backed up by good scientific evidence of success...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.